Axon Enterprise Financials
0HKE Stock | 577.42 76.92 15.37% |
Axon | Select Account or Indicator |
Understanding current and past Axon Enterprise Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Axon Enterprise's financial statements are interrelated, with each one affecting the others. For example, an increase in Axon Enterprise's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Axon Enterprise's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Axon Enterprise. Check Axon Enterprise's Beneish M Score to see the likelihood of Axon Enterprise's management manipulating its earnings.
Axon Enterprise Stock Summary
Axon Enterprise competes with TBC Bank, Applied Materials, Compagnie Plastic, Berner Kantonalbank, and FinecoBank SpA. Axon Enterprise is entity of United Kingdom. It is traded as Stock on LSE exchange.Specialization | Industrials, Commercial & Professional Services |
Instrument | UK Stock View All |
Exchange | London Exchange |
Business Address | 17800 North 85th |
Sector | Commercial Services & Supplies |
Industry | Industrials |
Benchmark | Dow Jones Industrial |
Website | www.axon.com |
Phone | 480 991 0797 |
You should never invest in Axon Enterprise without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Axon Stock, because this is throwing your money away. Analyzing the key information contained in Axon Enterprise's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Axon Enterprise Key Financial Ratios
There are many critical financial ratios that Axon Enterprise's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Axon Enterprise reports annually and quarterly.Revenue | 1.56 B | ||||
Gross Profit | 1.16 B | ||||
EBITDA | 194.63 M | ||||
Net Income | 174.23 M | ||||
Total Asset | 3.44 B |
Axon Enterprise Key Balance Sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 1.4B | 1.7B | 2.9B | 3.4B | 4.0B | 4.1B | |
Other Current Liab | 228.3M | 382.6M | 522.8M | 214.2M | 246.3M | 258.6M | |
Net Debt | (131.1M) | (329.4M) | 357.4M | 112.1M | 100.9M | 106.0M | |
Retained Earnings | 169.9M | 109.9M | 257.0M | 431.2M | 495.9M | 520.7M | |
Accounts Payable | 24.1M | 32.2M | 59.9M | 88.3M | 101.6M | 106.7M | |
Cash | 155.4M | 356.3M | 353.7M | 598.5M | 688.3M | 722.7M | |
Net Receivables | 293.1M | 501.2M | 555.1M | 693.5M | 797.5M | 837.4M | |
Inventory | 90.0M | 108.7M | 202.5M | 269.9M | 310.3M | 325.8M | |
Other Current Assets | 36.9M | 56.5M | 73.0M | 112.8M | 129.7M | 136.2M | |
Total Liab | 404.8M | 640.4M | 1.6B | 1.8B | 2.1B | 2.2B | |
Total Current Assets | 982.0M | 1.1B | 1.8B | 2.4B | 2.8B | 2.9B | |
Short Term Debt | 59.8M | 103.7M | 6.4M | 5.8M | 6.7M | 6.3M | |
Intangible Assets | 9.4M | 15.5M | 12.2M | 19.5M | 22.5M | 23.6M | |
Other Assets | 82.6M | 99.5M | 1.0 | 243.2M | 1.15 | 1.09 | |
Good Will | 25.2M | 43.6M | 45.0M | 57.9M | 66.6M | 70.0M | |
Other Liab | 99.8M | 129.5M | 201.4M | 269.6M | 310.1M | 155.7M | |
Net Tangible Assets | 505.7M | 941.6M | 988.8M | 1.2B | 1.4B | 771.4M |
Axon Enterprise Key Cash Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Change To Inventory | (52.2M) | (18.3M) | (96.0M) | (71.9M) | (64.7M) | (61.5M) | |
Change In Cash | (16.8M) | 200.9M | (886K) | 245.1M | 281.9M | 296.0M | |
Free Cash Flow | (34.4M) | 74.2M | 179.3M | 129.0M | 148.3M | 155.8M | |
Depreciation | 12.5M | 18.7M | 24.4M | 32.6M | 37.5M | 39.4M | |
Capital Expenditures | 72.9M | 50.3M | 56.1M | 59.6M | 68.6M | 72.0M | |
Net Income | (1.7M) | (60.0M) | 147.1M | 174.2M | 200.4M | 210.4M | |
End Period Cash Flow | 155.6M | 356.4M | 355.6M | 600.7M | 690.8M | 725.3M | |
Other Non Cash Items | 10.8M | (12.2M) | (87.0M) | 37.6M | 43.3M | 45.4M | |
Investments | (224.4M) | (283.8M) | 325.2M | (766.5M) | (689.8M) | (655.3M) | |
Change To Netincome | 78.0M | 128.5M | 209.1M | 44.6M | 51.3M | 92.1M |
Axon Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Axon Enterprise's current stock value. Our valuation model uses many indicators to compare Axon Enterprise value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Axon Enterprise competition to find correlations between indicators driving Axon Enterprise's intrinsic value. More Info.Axon Enterprise is rated fourth in return on equity category among its peers. It is rated fifth in return on asset category among its peers reporting about 0.14 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Axon Enterprise is roughly 7.17 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Axon Enterprise's earnings, one of the primary drivers of an investment's value.Axon Enterprise Systematic Risk
Axon Enterprise's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Axon Enterprise volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Axon Enterprise correlated with the market. If Beta is less than 0 Axon Enterprise generally moves in the opposite direction as compared to the market. If Axon Enterprise Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Axon Enterprise is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Axon Enterprise is generally in the same direction as the market. If Beta > 1 Axon Enterprise moves generally in the same direction as, but more than the movement of the benchmark.
Axon Enterprise Total Assets Over Time
Axon Enterprise February 27, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Axon Enterprise help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Axon Enterprise. We use our internally-developed statistical techniques to arrive at the intrinsic value of Axon Enterprise based on widely used predictive technical indicators. In general, we focus on analyzing Axon Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Axon Enterprise's daily price indicators and compare them against related drivers.
Information Ratio | (0.11) | |||
Maximum Drawdown | 20.76 | |||
Value At Risk | (5.96) | |||
Potential Upside | 2.71 |
Additional Tools for Axon Stock Analysis
When running Axon Enterprise's price analysis, check to measure Axon Enterprise's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axon Enterprise is operating at the current time. Most of Axon Enterprise's value examination focuses on studying past and present price action to predict the probability of Axon Enterprise's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axon Enterprise's price. Additionally, you may evaluate how the addition of Axon Enterprise to your portfolios can decrease your overall portfolio volatility.